Watchlist Price Alert

Sio Gene Therapies Inc. (SIOX)

NASDAQ: SIOX · Real-Time Price · USD

0.48

0.09 (23.14%)

At close: Feb 07, 2024, 8:58 PM

Sio Gene Therapies Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Net Income	-71.89M	-32.42M	-72.63M	-129.06M	-221.57M	-180.95M	-133.15M
Depreciation & Amortization	666K	2.47M	3.09M	2.45M	3.08M	249K	14K
Stock-Based Compensation	7.42M	4.49M	7.89M	16.43M	31.88M	36.37M	72.39M
Other Working Capital	1.22M	-6.4M	-6.01M	-16.83M	1.09M	23.92M	1.93M
Other Non-Cash Items	-410K	-782K	-1.58M	-4.94M	-2.94M	2.76M	5.58M
Deferred Income Tax	n/a	-10.87M	-947K	n/a	2.71M	-2.39M	-323K
Change in Working Capital	3.86M	-9.47M	-3.31M	-19.08M	-3.51M	31.84M	2.15M
Operating Cash Flow	-60.35M	-46.59M	-67.47M	-134.21M	-190.35M	-112.11M	-53.35M
Capital Expenditures	-695K	-398K	-255K	-202K	-4.28M	-105K	-5.35M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	4.34M	12.78M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	3.65M	12.39M	-255K	-202K	-4.28M	-105K	-5.35M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.44M	73.62M	41.48M	87.07M	136.4M	48.54M	334.94M
Financial Cash Flow	1.44M	73.62M	41.48M	87.07M	136.4M	48.54M	334.94M
Net Cash Flow	-55.26M	39.42M	-26.25M	-47.34M	-58.24M	-63.68M	276.25M
Free Cash Flow	-61.04M	-46.99M	-67.73M	-134.41M	-194.63M	-112.21M	-58.69M